Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2012 /
Drug susceptibility in cancer cell lines

4th - 7th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.12
Views: 2324

Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam

Dr Lodewyk Wessels discusses an initiative set up by the Netherland Cancer Institute and the Welcome Trust Sanger Institute working to assess the susceptibility of different cancer cell lines to different drugs.


This project is aimed to establish biomarkers for drug susceptibility helping to identify which patients will show drug resistant and potentially helping clinicians understand and overcome this resistance. Dr Wessels outlines the findings so far, and explains what implications this work could have on future treatment programmes.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation